Compare RDY & AG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RDY | AG |
|---|---|---|
| Founded | 1984 | 1979 |
| Country | India | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.9B | 8.5B |
| IPO Year | 2001 | 2004 |
| Metric | RDY | AG |
|---|---|---|
| Price | $12.22 | $19.56 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $16.90 | ★ $21.92 |
| AVG Volume (30 Days) | 2.2M | ★ 8.3M |
| Earning Date | 05-12-2026 | 05-12-2026 |
| Dividend Yield | ★ 0.52% | 0.12% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $7.72 | $24.41 |
| Revenue Next Year | $3.50 | $10.68 |
| P/E Ratio | ★ $18.67 | $143.01 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.36 | $10.19 |
| 52 Week High | $15.67 | $32.00 |
| Indicator | RDY | AG |
|---|---|---|
| Relative Strength Index (RSI) | 53.86 | 49.65 |
| Support Level | $12.09 | $18.43 |
| Resistance Level | $12.48 | $20.00 |
| Average True Range (ATR) | 0.18 | 0.77 |
| MACD | 0.03 | -0.30 |
| Stochastic Oscillator | 82.25 | 34.50 |
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly 40% of its generics sales, with other key markets being India (20%) and Europe (20%). Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
First Majestic Silver Corp is in the business of production, development, exploration, and acquisition of mineral properties with a focus on silver and gold production in North America. The company owns four producing mines in Mexico, consisting of the Santa Elena Silver/Gold Mine, the San Dimas Silver/Gold Mine, the Los Gatos Silver Mine, and the La Encantada Silver Mine. It also owns the Jerritt Canyon Gold Mine in Nevada, USA. Additionally, the firm holds interests in the San Martin Silver Mine and the Del Toro Silver Mine, and several exploration-stage projects. The majority of the company's revenues are from the sale of precious metals contained in dore and concentrate form. It generates maximum revenue from the sale of silver, followed by gold, zinc, copper, and other metals.